Literature DB >> 17724541

Transfusion-related acute lung injury.

Antonio Fabron1, Larissa Barbosa Lopes, José Orlando Bordin.   

Abstract

Transfusion-related acute lung injury (TRALI) is a serious clinical syndrome associated with the transfusion of plasma-containing blood components. Recently, TRALI has come to be recognized as the leading cause of transfusion-related death in the United States and United Kingdom. This complication typically presents as shortness of breath, hypoxemia, hypotension, fever and noncardiogeneic pulmonary edema, all occurring during or within 6 h after transfusion. Although the mechanism of TRALI has not been fully elucidated, it has been associated with human leukocyte antigen antibodies (class I, class II or neutrophil alloantigens) and with biologically active mediators in stored cellular blood components. Most of the donors implicated in cases of TRALI are multiparous women. Rarely diagnosed, TRALI can be confused with other causes of acute respiratory failure. Greater knowledge regarding TRALI on the part of clinicians could be crucial in preventing and treating this severe complication of blood transfusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724541     DOI: 10.1590/s1806-37132007000200016

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  3 in total

1.  Microparticles in stored red blood cells as potential mediators of transfusion complications.

Authors:  Wenche Jy; Marco Ricci; Sherry Shariatmadar; Orlando Gomez-Marin; Lawrence H Horstman; Yeon S Ahn
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

2.  Blood banking-induced alteration of red blood cell oxygen release ability.

Authors:  Yaojin Li; Yanlian Xiong; Ruofeng Wang; Fuzhou Tang; Xiang Wang
Journal:  Blood Transfus       Date:  2015-10-29       Impact factor: 3.443

3.  Mortality reduction in pediatric patients with severe fatal human adenoviral pneumonia treated with high titer neutralizing antibodies (NAbs) plasma: a retrospective cohort study.

Authors:  Hongyan Peng; Feiyan Chen; Yunlong Zuo; Bolun Huang; Yiyu Yang; Run Dang
Journal:  BMC Pediatr       Date:  2022-03-22       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.